A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants

NCT05999708 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study terminated prior to FSFV for strategic business reasons.

Conditions

Colitis, Ulcerative

Interventions

DRUG: GSK4381406
DRUG: Placebo
DRUG: Indomethacin

Sponsor

GlaxoSmithKline